Showing 141-150 of 1718 results for "".
Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/diseases-diagnoses/neuromuscular/diagnosis-of-chronic-inflammatory-demyelinating-polyneuropathy/32112/Due to the heterogeneous presentation of this complex disease, diagnosis is not always straightforward, and proper interpretation of clinical and diagnostic data is crucial to avoid misdiagnosis.Brain Imaging in Differential Diagnosis of Dementia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.Toward Precision Medicine for Genetic Epilepsies: Glucose Transporter Type 1 Deficiency Syndrome
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/toward-precision-medicine-for-genetic-epilepsies-glucose-transporter-type-1-deficiency-syndrome/32055/As we begin to understand the mechanisms of specific genetic epilepsies, tailored treatments have the potential to be transformative, as in GLUT1-DS.Neuromuscular Amyloidosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-amyloidosis/31815/The most common amyloidosis are both treatable; accurate diagnosis is paramount.Friedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c
March 2016 Case Challenge: A Woman with Muscle Stiffness
https://practicalneurology.com/diseases-diagnoses/neuromuscular/march-2016-case-challenge-a-woman-with-muscle-sti/31088/A 34-year-old woman presented with muscle stiffness worsened by cold temperature and stress. The demonstrated sign can be seen in: 1. Paramyotonia congenita (PMC) 2. Myotonia congenita (MC) 3. Hypokalemic periodic paralysis (HypoKPP) 4. Polymyositis 5. Oculopharyngeal muscular dystrophy The correcMovement Disorders Moment: Incorporating Lifestyle Medicine Into Parkinson Disease Care—Evidence and Guidance for Clinical Practice
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-incorporating-lifestyle-medicine-into-parkinson-disease-care-evidence-and-guidance-for-clinical-practice/32196/Lifestyle medicine strategies play an important role in managing Parkinson disease and empowering patients and their care partners.Spinal Muscular Atrophy
https://practicalneurology.com/diseases-diagnoses/child-neurology/spinal-muscular-atrophy/31554/A devastating disease now has 2 approved breakthrough treatments available.